Hepatitis A virus-specific BSC-1 cells were used for the detection of serum immunoglobulins to hepatitis A virus by indirect immunofluorescence. Of 150 serum samples tested, specific immunoglobulin M was detected only in patients with serologically confirmed acute hepatitis A, while specific immunoglobulin G was detected in patients with acute or past clinical hepatitis A as well as many patien...

While several predictors of an early and sustained response can be identified in the treatment of chronic hepatitis B, no consistently demonstrable predictors of response exist for chronic hepatitis C. As such, guidelines for the treatment of chronic hepatitis C are more complex than those for hepatitis B. The treatment options for chronic hepatitis B and C are outlined and there is speculation...

Infection with the delta agent can only occur in the context of coexistent hepatitis B virus infection. We describe a patient in whom the clinical features of acute delta hepatitis developed when seroconversion from hepatitis B surface antigen to antibody had already occurred and diagnosis of recent acute hepatitis B was based on high titre IgM antibody to hepatitis B core antigen. We discuss t...

HSV hepatitis is a rare but often fatal cause of liver failure which tends to affect immunocompromised individuals. Early treatment with Acyclovir has been shown to reduce mortality in HSV hepatitis making recognition of the condition critically important. Here, we present a case of HSV hepatitis in a young woman with Crohn's disease on Prednisone, Azathioprine, and Infliximab. We discuss the c...

Hepatitis A (HAV) causes one of the most common infectious diseases in the world and may produce clinical conditions ranging from a-symptomatic infection to acute liver failure. Hepatitis A infection is an endemic problem in most African and South American Countries, meanwhile its incidence has largely declined over the last 2 decades in Western Europe and USA [1, 2]. The traditional preventive...

BACKGROUND Infections contracted during infancy or childhood are responsible for 42 percent of case of chronic hepatitis B disease, and in 25 percent or more these infections result in death from hepatoma or cirrhosis during adulthood. Hepatitis B vaccine and immune globulin provide the means of preventing the disease and its sequelae, but their proper use requires clinical strategies for decid...

Background. The Republic of Sakha (Yakutia) is an endemic region for chronic hepatitis D, where the detection rate antibodies to delta virus 35% [3]. urgency problem HDV infection also determined by its aggressive and rapidly progressive course. In 2019, Bulevirtide, a drug treatment hepatitis, was registered in Russia. Three randomized trials showed high virological, biochemical response, as w...